The Market Statsville Group(MSG)publishes the new report on theCell Therapy Marketby Use-Type (Clinical-use (Therapeutic Area and Cell Type) and Research-use), by Therapy Type (Allogenic Therapies and Autologous Therapies), by Region Global Share and Forecast to 2030.The global cell therapy market size is projected to grow USD 23.9 billion by 2030 from USD 8.1 billion in 2021, registering a CAGR of 14.5% during the forecastperiod. Continue reading →

Gene and stem cell therapy research is beginning to gain stride in ophthalmology, as various agents for an array of indications have begun reporting phase 2/3 outcomes with benefits ranging from reduced treatment burden to reversal of chronic vision loss. Continue reading →

By now, the complexity of COVID-19 is well known, if not well understood. One of the mysteries is so-called brain fog, or cognitive issues such as confusion or forgetfulness that occur as a result of Long Covid Continue reading →

Health and medicine | Honors and awards | News releases | Science May 6, 2022 Another lovely day at the University of Washingtons Seattle campus.Pamela Dore/University of Washington Four faculty members at the University of Washington have been elected to the National Academy of Sciences. The new members from the UW are: They are among 120 new members and 30 international members to the National Academy of Sciences this year. Election recognizes achievement in science by election to membership, and with the National Academy of Engineering and the National Academy of Medicine provides science, engineering, and health policy advice to the federal government and other organizations, according to an announcement May 3 by the academy Continue reading →

Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and autoimmune diseases Boston, MA. May 4, 2022 -- Mass General Brigham today revealed the annual Disruptive Dozen, 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in the next several years. The Disruptive Dozen results from interviews of 50 Mass General Brigham senior Harvard faculty followed by a rigorous selection process to identify the 12 most likely to have significant impact on patient care in the next few years Continue reading →

There are dozens of studies, innovations, and research findings released everyday by institutions and clinics across the world. Heres a look at some of the other notable health reports from May 5 Continue reading →

Stefania Pelfini, La Waziya PhotographyGetty Images Fifteen years ago, scientists made a stirring discovery when they demonstrated that they could reverse the process of aging in cells. By activating a set of four factors in the DNA, they reset the cells clock to zero, reverting adult cells to their embryonic state. The factors were named Yamanaka factors after their discoverer, Shinya Yamanaka, and a few years later, they earned him a Nobel Prize Continue reading →

Gilead to License Exclusive Worldwide Rights to the Investigational Candidate DF7001, a 5T4-Targeting NK Cell Engager for Solid Tumors Gilead to Have Options to License Several Additional NK Cell Engager Programs FOSTER CITY, Calif. & WALTHAM, Mass.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) and Dragonfly Therapeutics today announced a collaboration designed to advance a number of Dragonfly's novel natural killer (NK) cell engager-based immunotherapies for oncology and inflammation indications Continue reading →

Visit the News Hub Immune system may be key to new therapies for cardiac diseases A new grant for researchers at Washington University School of Medicine in St. Continue reading →